| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 767431 | 90267 | POMALIDOMIDA SALA 3 MG CAPSULAS DURAS EFG | POMALIDOMIDA SALA 3 MG CAPSULAS DURAS EFG, 21 cápsulas (PVC/PCTFE /Aclar) | 3 mg | 5 | 21 | 43 | 21 cápsulas (PVC/PCTFE /Aclar) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90267/90267_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90267/90267_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 767435 | 90268 | POMALIDOMIDA SALA 4 MG CAPSULAS DURAS EFG | POMALIDOMIDA SALA 4 MG CAPSULAS DURAS EFG, 21 cápsulas (PVC/PCTFE /Aclar) | 4 mg | 5 | 21 | 43 | 21 cápsulas (PVC/PCTFE /Aclar) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90268/90268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90268/90268_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 766981 | 90155 | AIQLARA COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AIQLARA COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | (0 mg/3 mg) + (2 mg/2 mg) + (3 mg/2 mg) + (0 mg/1 mg) | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90155/90155_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90155/90155_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2025-02-19 | 1 | 1 | 1 | 2025-02-20 | 2025-02-19 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 766982 | 90155 | AIQLARA COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AIQLARA COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3x28) comprimidos | (0 mg/3 mg) + (2 mg/2 mg) + (3 mg/2 mg) + (0 mg/1 mg) | 5 | 84 | 10 | 84 (3x28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90155/90155_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90155/90155_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2025-02-19 | 1 | 1 | 1 | 2025-02-20 | 2025-02-19 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 767364 | 90098 | PLYZARI 6 MG/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA | PLYZARI 6 MG/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA, 5 plumas precargadas de 3 ml | 6 mg/ml inyectable 3 ml | 66 | 5 | 49 | 5 plumas precargadas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90098/90098_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90098/90098_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8183 | ZENTIVA SPAIN S.L.U. | 2025-04-01 | 1 | 1 | 1 | 2025-04-01 | 2025-04-01 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 768849 | 5610201301IP | CRESTOR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CRESTOR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/5610201301IP/5610201301IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1236 | DIFARMED S.L.U. | 2025-10-20 | 1 | 1 | 1 | 2025-10-21 | 2025-10-20 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 768932 | BE318254IP1 | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318254IP1/BE318254IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | DIFARMED S.L.U. | 2025-10-23 | 1 | 1 | 1 | 2025-10-24 | 2025-10-23 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 768933 | BE318272IP1 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318272IP1/BE318272IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | DIFARMED S.L.U. | 2025-10-23 | 1 | 1 | 1 | 2025-10-24 | 2025-10-23 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769496 | LT1983805025IP3 | CARDYL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805025IP3/LT1983805025IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ABACUS MEDICINE A/S | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769498 | 8194201506 | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8194201506/8194201506_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ABACUS MEDICINE A/S | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769499 | LT1983805063 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805063/LT1983805063_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | ABACUS MEDICINE A/S | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769246 | 1251983001 | ACVYBRA 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | ACVYBRA 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 60 mg | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251983001/1251983001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251983001/1251983001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36528 | REDDY PHARMA IBERIA S.A. | 2025-11-24 | 1 | 1 | 1 | 2025-11-25 | 2025-11-24 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769245 | 1251982001 | XBONZY 120 MG SOLUCION INYECTABLE | XBONZY 120 MG SOLUCION INYECTABLE, 1 vial de 1,7 ml | 120 mg inyectable 1,7 ml | 45 | 1 | 34 | 1 vial de 1,7 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251982001/1251982001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251982001/1251982001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 36528 | REDDY PHARMA IBERIA S.A. | 2025-11-24 | 1 | 1 | 1 | 2025-11-25 | 2025-11-24 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 732225 | 86407 | RIVAROXABAN SANDOZ 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RIVAROXABAN SANDOZ 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC/Al) | 15 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86407/86407_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86407/86407_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2022-04-05 | 1 | 1 | 1 | 2022-04-05 | 2022-04-05 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 732240 | 86407 | RIVAROXABAN SANDOZ 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RIVAROXABAN SANDOZ 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 42 comprimidos (PVC/PVDC/Al) | 15 mg | 5 | 42 | 10 | 42 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86407/86407_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86407/86407_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2022-04-05 | 1 | 1 | 1 | 2022-04-05 | 2022-04-05 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 732246 | 86408 | RIVAROXABAN SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RIVAROXABAN SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 10 comprimidos (PVC/PVDC/Al) | 10 mg | 5 | 10 | 10 | 10 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86408/86408_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86408/86408_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2022-04-05 | 1 | 1 | 1 | 2022-04-05 | 2022-04-05 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 732251 | 86408 | RIVAROXABAN SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RIVAROXABAN SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (PVC/PVDC/Al) | 10 mg | 5 | 30 | 10 | 30 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86408/86408_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86408/86408_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2022-04-05 | 1 | 1 | 1 | 2022-04-05 | 2022-04-05 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 732282 | 86414 | RIVAROXABAN SANDOZ 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RIVAROXABAN SANDOZ 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC-Al) | 20 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC-Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86414/86414_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86414/86414_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2022-04-05 | 1 | 1 | 1 | 2022-04-05 | 2022-04-05 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 732314 | 86415 | RIVAROXABAN SANDOZ 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RIVAROXABAN SANDOZ 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 2,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86415/86415_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86415/86415_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2022-04-05 | 1 | 1 | 1 | 2022-04-05 | 2022-04-05 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 764904 | 89556 | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89556/89556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89556/89556_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2024-06-03 | 1 | 1 | 1 | 2024-06-03 | 2024-06-03 | 1 | 2025-12-14 | View Edit Delete |
Page 31 of 1036, showing 20 records out of 20715 total, starting on record 601, ending on 620